The Hippocrates Initiative began in 2009 as the Hippocrates Prize for Poetry and Medicine for an unpublished poem on a medical subject.†The Hippocrates Initiative now also includes the international†Hippocrates Society for Poetry and Medicine,†annual international symposia†at which the Hippocrates awards are also presented, an international research forum for poetry and medicine,†The Hippocrates Press, and†workshops, the first held in Venice†in September 2013.
Since its launch in 2009, the annual Hippocrates Prize has attracted thousands of entries from over 60 countries, from the Americas to Fiji and from Finland to Australasia.
Major support for the Hippocrates initiative has come from the†Fellowship of Postgraduate Medicine,†with additional support from the†Wellcome Trust,†the†Cardiovascular Research Trust,†the†National Association for Writers in Education,†and Heads, Teachers and Industry, and the University of Warwick's†Institute of Advanced Study.††
Co-founder: Michael Hulse
Michael Hulse has won numerous awards for his poetry, and has translated more than sixty books from the German, among them works by W. G. Sebald, Goethe and Rilke. His collection of poetry, The Secret History (Arc, 2009), and the co-edited anthology The Twentieth Century in Poetry (Ebury, 2011), brought him invitations to read and talk in Mexico, the US, Australia, New Zealand, and several European countries. He is a permanent judge of the GŁnter Grass Foundation’s Albatross Prize, a literary award similar to Britain’s Man Booker International. With J. M. Coetzee and Susanna Moore, is an ambassador for Adelaide Writers’ Week. His new book of poems, Half-Life, was published by Arc in August 2013.
Co-founder: Donald Singer
Donald Singer is a clinical pharmacologist who has published over 170 articles, chapters and books on cardiovascular research, prevention and treatment, and public understanding of health. He co-authors Pocket Prescriber, the 8th edition of which was published by Taylor & Francis in 2015. He is President of the Fellowship of Postgraduate Medicine and chairs the advisory board of the FPM’s journal Health Policy and Technology. He is also on the Executive Committee of the European Association of Clinical Pharmacology and Therapeutics, which supports scientific and educational exchange for over 4000 clinical pharmacologists from 34 European and other countries.†